Sexual health and health‐related quality of life among women with pulmonary arterial hypertension
Open Access
- 1 August 2018
- journal article
- research article
- Published by Wiley in Pulmonary Circulation
- Vol. 8 (4) , 1-10
Abstract
Pulmonary arterial hypertension (PAH) is characterized by progressive limitations in physical activity and health‐related quality of life (HRQoL). HRQoL deficits may extend beyond the traditional domains of physical activity, psychological health, and emotional wellbeing to sexual health and function. Sexual HRQoL has not been studied in PAH, nor has the impact of PAH therapies themselves on sexual health and intimacy. In this initial investigation, we sought to explore HRQoL among women diagnosed with PAH and to determine if PAH treatment type (intravenous or subcutaneous prostanoids versus oral medications) was associated with levels of self‐reported HRQoL assessed by validated measures for PAH‐specific, general, and sexual HRQoL. We administered the emPHasis‐10, Short Form (SF)‐36, Female Sexual Dysfunction Scale‐Revised (FSDS‐R), and the Arizona Sexual Experience Scale (ASEX) to 35 women with self‐reported World Health Organization Group 1 PAH at the 2016 Pulmonary Hypertension Association International Conference and Scientific Sessions. HRQoL instruments demonstrated excellent internal reliability. Women with PAH had high levels of sexual distress captured with the FSDS‐R scale. The FSDS‐R (but not ASEX) was significantly correlated to emPHasis‐10 (r = 0.64, p < 0.01) and most SF‐36 domains (r = − 0.36 to − 0.64, p < 0.05). Participants treated with intravenous or subcutaneous prostanoids had higher (worse) FSDS‐R scores than those on oral therapies while ASEX, emPHasis‐10, and SF‐36 scores were similar across treatment types. Sexual HRQoL may impact overall quality of life in PAH and specific assessment of sexual health and functioning within intimate relationships may detect deficits in wellbeing not addressed by established HRQoL metrics. Further study to address all aspects of HRQoL in PAH is required.Keywords
Funding Information
- National Institute of General Medical Sciences
- National Institutes of Health (P20GM1403652)
- National Institutes of Health (R01 HL141268)
- National Institute of General Medical Sciences (P20GMI403652)
This publication has 55 references indexed in Scilit:
- Sexual Satisfaction and the Importance of Sexual Health to Quality of Life Throughout the Life Course of U.S. AdultsThe Journal of Sexual Medicine, 2016
- Linguistic Validation of The Emphasis-10 Questionnaire: A Patient-Reported Outcome Instrument For Assessing Qol In Pulmonary Hypertension (Ph)Value in Health, 2015
- Using an FSDS-R Item to Screen for Sexually Related Distress: A MsFLASH AnalysisSexual Medicine, 2015
- Sexual Function in Patients Supported with Left Ventricular Assist Device and with Heart TransplantESC Heart Failure, 2014
- Emotional symptoms and quality of life in patients with pulmonary arterial hypertensionThe Journal of Heart and Lung Transplantation, 2014
- Reliability and validity of the Arizona Sexual Experiences Scale-Arabic version in Tunisian patients with schizophreniaComprehensive Psychiatry, 2014
- Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: Insights from the REVEAL RegistryThe Journal of Heart and Lung Transplantation, 2013
- Sexual Dysfunction in Men with COPD: Impact on Quality of Life and SurvivalLung, 2012
- Pregnancy in women with pulmonary hypertensionNetherlands Heart Journal, 2011
- Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial HypertensionJACC, 2009